{
  "meta": {
    "title": "10_Menopause",
    "url": "https://brainandscalpel.vercel.app/10-menopause-6b23289b.html",
    "scrapedAt": "2025-11-30T06:56:48.792Z"
  },
  "questions": [
    {
      "id": 88720,
      "choices": [
        {
          "id": 263336,
          "text": "Gonadotropin secretion"
        },
        {
          "id": 263337,
          "text": "LDL-cholesterol"
        },
        {
          "id": 263338,
          "text": "Bone mass"
        },
        {
          "id": 263339,
          "text": "Muscle mass"
        }
      ],
      "text": "Estrogen administration in a menopausal woman increases the:",
      "unique_key": "Q3645406",
      "question_audio": null,
      "question_video": null,
      "map_id": 34244944,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) During the reproductive years of life, natural oestrogens are principally produced by the Graafian follicles in response to pituitary gonadotropins. Oestrogen is responsible for the development of secondary sex characters, including the breasts, provides the negative feedback signal to the pituitary gland and hypothalamus and maintains adequate mineralization of the bones. While in menopausal women – estrogen is used for Short term—hot flushes, vasomotor symptoms n Dyspareunia, libido n Urethral syndrome Long term—osteoporosis n Cardiovascular n Alzheimer’s disease<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/3(622).jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 263338,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52090391701093707/52090391701093707.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52090391701093707/52090391701093707.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88721,
      "choices": [
        {
          "id": 263340,
          "text": "Reduces fracture rates"
        },
        {
          "id": 263341,
          "text": "Avoids endometrial hyperplasia"
        },
        {
          "id": 263342,
          "text": "Reduces the incidence of venous thrombosis"
        },
        {
          "id": 263343,
          "text": "No increase in incidence of breast carcinoma"
        }
      ],
      "text": "All of the following are the advantages of using Raloxifene over estrogen in post menopausal women except:",
      "unique_key": "Q2212598",
      "question_audio": null,
      "question_video": null,
      "map_id": 34974342,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Reduces the incidence of venous thrombosis. Explanation for Correct Answer (C): Raloxifene, a selective estrogen receptor modulator (SERM), has been shown to increase the risk of venous thrombosis (deep vein thrombosis and pulmonary embolism) in postmenopausal women. This is one of the key differences between raloxifene and estrogen. While estrogen has been associated with similar risks, raloxifene does not reduce the incidence of venous thrombosis; rather, it may increase the risk, making it a disadvantage compared to other options. Explanation for Incorrect Answers: A. Reduces fracture rates: One of the major advantages of raloxifene over estrogen is that it reduces fracture rates, especially vertebral fractures. It works by mimicking estrogen’s effects on bone density without stimulating the uterus or breasts, thus reducing the risk of osteoporosis-related fractures in postmenopausal women. B. Avoids endometrial hyperplasia: Unlike estrogen, which can stimulate the endometrium and lead to endometrial hyperplasia (a precursor to endometrial cancer), raloxifene does not cause this issue. This is one of the key benefits of raloxifene because it provides the benefits of estrogen on bone health without the risk of endometrial complications. D. No increase in incidence of breast carcinoma: Raloxifene has been shown to reduce the risk of breast cancer in postmenopausal women, particularly estrogen receptor-positive breast cancer. It provides the benefits of estrogen-like effects on bones while having anti-estrogenic effects on breast tissue, which lowers the risk of breast carcinoma compared to estrogen therapy.",
      "correct_choice_id": 263342,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29502891701093735/29502891701093735.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29502891701093735/29502891701093735.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88722,
      "choices": [
        {
          "id": 263344,
          "text": "Progesterone"
        },
        {
          "id": 263345,
          "text": "Estrogen and progesterone"
        },
        {
          "id": 263346,
          "text": "Estrogen"
        },
        {
          "id": 263347,
          "text": "None"
        }
      ],
      "text": "A 48-year-old female suffering from severe menorrhagia (DUB) underwent hysterectomy She wishes to take hormone replacement therapy. Physical examination and brest are normal but X-ray shows osteoporosis. The treatment of choice is:",
      "unique_key": "Q5676099",
      "question_audio": null,
      "question_video": null,
      "map_id": 34336739,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Estrogen. Explanation for Correct Answer (C): In a post-hysterectomy patient who has no uterus, estrogen replacement therapy (ERT) is the treatment of choice. Since she no longer has a uterus, there is no need for progesterone to protect the endometrium from hyperplasia (a concern in women with a uterus). Estrogen alone can effectively manage menopausal symptoms such as hot flashes and osteoporosis, which is the case for this patient who has been diagnosed with osteoporosis. Estrogen therapy will help prevent further bone loss and reduce fracture risk, which is the primary concern in this patient. Explanation for Incorrect Answers: A. Progesterone: Progesterone is used in combination with estrogen in women who still have a uterus, to protect the endometrium from the proliferative effects of estrogen. Since this patient has undergone a hysterectomy and no longer has a uterus, progesterone is unnecessary in her treatment. B. Estrogen and progesterone: Combination therapy of estrogen and progesterone is typically indicated for women with a uterus to prevent endometrial hyperplasia. However, this patient has had a hysterectomy and does not require progesterone for this purpose, making the combination therapy unnecessary and not the best treatment option. D. None: Estrogen replacement therapy is the appropriate treatment for this patient, especially for managing osteoporosis and menopausal symptoms following hysterectomy.",
      "correct_choice_id": 263346,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76079451701093756/76079451701093756.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76079451701093756/76079451701093756.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88723,
      "choices": [
        {
          "id": 263348,
          "text": "Ethiny estradiol"
        },
        {
          "id": 263349,
          "text": "Testosterone"
        },
        {
          "id": 263350,
          "text": "Fluoxymesteron"
        },
        {
          "id": 263351,
          "text": "Danazol"
        }
      ],
      "text": "Basanti devi 45 years old women presents with hot flushes after stopping of menstruation, ‘Hot Flush’ can be relieved by administration of following agents:",
      "unique_key": "Q2844349",
      "question_audio": null,
      "question_video": null,
      "map_id": 34231417,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hot flushes are the waves of vasodilation affecting the face and the neck and these last for 2–5 min each. These are followed by severe sweating. Several of these flushes occur in a day, but are more severe during the night, and can disturb sleep. The hot flushes are sometimes preceded by headache. Palpitation and anginal pains may be felt. Hot flushes are caused by noradrenaline, which disturbs the thermoregulatory system. Oestrogen deficiency reduces hypothalamic endorphins, which release more norepinephrine and serotonin. This leads to inappropriate heat loss mechanism Hence estrogen theraphy is given for treatment of hot flushes.",
      "correct_choice_id": 263348,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39252741701097095/39252741701097095.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39252741701097095/39252741701097095.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88724,
      "choices": [
        {
          "id": 263352,
          "text": "Androgens"
        },
        {
          "id": 263353,
          "text": "Raloxifene"
        },
        {
          "id": 263354,
          "text": "Isoflavones"
        },
        {
          "id": 263355,
          "text": "Tibolone"
        }
      ],
      "text": "All the following appear to decrease hot flushes in menopausal women except:",
      "unique_key": "Q6718260",
      "question_audio": null,
      "question_video": null,
      "map_id": 34131137,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Raloxifene, a nonsteroidal compound (Evista), is a selective oestrogen receptor modulator (SERM), Side effects are hot flushes, cramps, increased incidence of venous thrombosis and retinopathy. Hence raloxifene not used in hot flushes Tibolone (Livial) is a synthetic derivative of 19-nortestosterone and has a weak oestrogenic, progestogenic and androgenic action. It also elevates the mood, relieves the vasomotor symptoms Isoflavones and androgens can also be used for hot flushes",
      "correct_choice_id": 263353,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28677861701097112/28677861701097112.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28677861701097112/28677861701097112.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88725,
      "choices": [
        {
          "id": 263356,
          "text": "Thrombosis"
        },
        {
          "id": 263357,
          "text": "Fibrocystic disese"
        },
        {
          "id": 263358,
          "text": "Fibroadenoma"
        },
        {
          "id": 263359,
          "text": "Hemorrhage"
        }
      ],
      "text": "Absolute contraindication of hormone replacement therapy is:",
      "unique_key": "Q8206494",
      "question_audio": null,
      "question_video": null,
      "map_id": 34989459,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Thrombosis. Explanation for Correct Answer (A): Thrombosis is an absolute contraindication for hormone replacement therapy (HRT). Estrogen can increase the risk of blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE), by enhancing blood coagulation. For women with a history of or current thrombosis, HRT is contraindicated because it significantly increases the risk of further thrombotic events. Explanation for Incorrect Answers: B. Fibrocystic disease: Fibrocystic breast disease, characterized by lumpy, tender breasts, is not an absolute contraindication for HRT. Although HRT can sometimes exacerbate symptoms in women with fibrocystic breasts, it is not a contraindication for use unless there are other concerns like a history of breast cancer. C. Fibroadenoma: Fibroadenomas are benign breast tumors, and while there may be concerns about HRT affecting breast tissue, fibroadenomas are not considered an absolute contraindication to HRT. However, careful monitoring and individualized risk assessment should be done in these cases. D. Hemorrhage: While uterine bleeding or abnormal hemorrhage may suggest an underlying condition like endometrial cancer, hemorrhage itself is not an absolute contraindication to HRT. It is important to first determine the cause of the bleeding, and if it is due to a malignancy or other serious condition, HRT should be avoided. However, hemorrhage alone does not universally rule out HRT.",
      "correct_choice_id": 263356,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62215961701097125/62215961701097125.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62215961701097125/62215961701097125.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88726,
      "choices": [
        {
          "id": 263360,
          "text": "Menstrual irregularity"
        },
        {
          "id": 263361,
          "text": "Hot flushes"
        },
        {
          "id": 263362,
          "text": "bone mass"
        },
        {
          "id": 263363,
          "text": "Cessation of menstruation"
        }
      ],
      "text": "Marker for perimenopause transition is :",
      "unique_key": "Q5829937",
      "question_audio": null,
      "question_video": null,
      "map_id": 34928764,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Menstrual irregularity. Explanation for Correct Answer (A): Menstrual irregularity is a key marker for the perimenopausal transition. This stage, which occurs before menopause, is characterized by fluctuations in menstrual cycle length, frequency, and flow. As ovarian function declines, the production of estrogen and progesterone becomes erratic, leading to changes in the menstrual cycle. These irregularities are often the first noticeable sign of approaching menopause. Explanation for Incorrect Answers: B. Hot flushes: While hot flashes (flushes) are a common symptom of perimenopause and menopause, they typically occur later in the perimenopausal phase, rather than being the first marker. Hot flashes are associated with the hormonal changes in perimenopause but are not the earliest sign. C. Bone mass: Changes in bone mass, such as bone loss, occur during and after the menopausal transition due to a decrease in estrogen levels. However, a decrease in bone mass is not a marker for the perimenopausal transition itself, as it takes a longer period of time to become noticeable compared to menstrual irregularities. D. Cessation of menstruation: The cessation of menstruation marks the end of menopause, not the transition to perimenopause. Menopause is confirmed after 12 consecutive months of no menstrual periods, which occurs after the perimenopausal phase.",
      "correct_choice_id": 263360,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62722051701096987/62722051701096987.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62722051701096987/62722051701096987.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88727,
      "choices": [
        {
          "id": 263364,
          "text": "30-49 years"
        },
        {
          "id": 263365,
          "text": "35-49 years"
        },
        {
          "id": 263366,
          "text": "39-51 years"
        },
        {
          "id": 263367,
          "text": "40-60 years"
        }
      ],
      "text": "Perimenopause age of a female is from :",
      "unique_key": "Q1677598",
      "question_audio": null,
      "question_video": null,
      "map_id": 34806245,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) 39-51 years. Explanation for Correct Answer (C): Perimenopause typically occurs between the ages of 39 and 51 years. This phase is characterized by hormonal fluctuations as a woman transitions toward menopause, marking the period before the final menstrual period. The average age for the onset of perimenopause is around 45, and it usually lasts several years, ending when a woman has had 12 consecutive months without menstruation, marking the beginning of menopause. Explanation for Incorrect Answers: A. 30-49 years: This range is too broad and not typical for perimenopause. While some women may experience early perimenopausal symptoms in their late 30s, perimenopause most commonly begins in the early to mid-40s, making this range inaccurate. B. 35-49 years: Although perimenopause may begin around 35 for some women, it is more commonly experienced between ages 39 and 51. The earlier age of 35 is considered early onset, and while it can happen, it is less typical than the range of 39-51. D. 40-60 years: This range extends too far beyond the typical age range for perimenopause. While menopause itself can occur later, perimenopause is usually finished by the early 50s, with 60 being well beyond the normal age for perimenopause onset.",
      "correct_choice_id": 263366,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35425711701096998/35425711701096998.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35425711701096998/35425711701096998.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88728,
      "choices": [
        {
          "id": 263368,
          "text": "Serum FSH > 40"
        },
        {
          "id": 263369,
          "text": "Serum LH > 20"
        },
        {
          "id": 263370,
          "text": "Serum FSH <40"
        },
        {
          "id": 263371,
          "text": "Serum estradiol < 30"
        }
      ],
      "text": "Which of these is diagnostic of menopause?",
      "unique_key": "Q3827334",
      "question_audio": null,
      "question_video": null,
      "map_id": 34154837,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Serum FSH > 40. Explanation for Correct Answer (A): A serum FSH (follicle-stimulating hormone) level greater than 40 IU/L is diagnostic of menopause. During menopause, the ovaries' ability to produce estrogen declines significantly, leading to a lack of negative feedback on the hypothalamus and pituitary. This results in elevated levels of FSH, which stimulates the ovaries in an attempt to maintain follicular function. FSH levels above 40 IU/L are typically seen in postmenopausal women, confirming the transition to menopause. Explanation for Incorrect Answers: B. Serum LH > 20: While luteinizing hormone (LH) levels may also rise during menopause due to the lack of negative feedback from estrogen, an LH level > 20 is not diagnostic of menopause. It is FSH levels that are more reliably used to confirm menopause. C. Serum FSH < 40: A serum FSH level lower than 40 IU/L would not be consistent with menopause. In the peri-menopausal phase, FSH levels fluctuate, but they do not typically decrease to below 40 until after menopause. Lower levels of FSH would be more typical of premenopausal women with normal ovarian function. D. Serum estradiol < 30: While serum estradiol (a form of estrogen) levels are low in menopause, a level less than 30 pg/mL is not a definitive diagnostic criterion for menopause. Estradiol can fluctuate during the perimenopausal period, and its measurement alone does not confirm menopause. Elevated FSH is a more specific diagnostic marker.",
      "correct_choice_id": 263368,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64339171701097011/64339171701097011.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64339171701097011/64339171701097011.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88729,
      "choices": [
        {
          "id": 263372,
          "text": "They are not related to her changing levels of estrogen and progesterone."
        },
        {
          "id": 263373,
          "text": "They commonly include depression, irritability, poor concentration, and impaired memory."
        },
        {
          "id": 263374,
          "text": "They are related to a drop in gonadotropin levels."
        },
        {
          "id": 263375,
          "text": "They are not affected by environmental factors."
        },
        {
          "id": 263376,
          "text": "They are primarily a reaction to the cessation of menstrual flow."
        }
      ],
      "text": "A 55-year-old woman presents to your office for consultation regarding her symptoms of menopause. She stopped having periods 8 months ago and is having severe hot flushes. The hot flushes are causing her considerable stress. What should you tell her regarding the psychologic symptoms of the climacteric?",
      "unique_key": "Q1323210",
      "question_audio": null,
      "question_video": null,
      "map_id": 34327233,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) They commonly include depression, irritability, poor concentration, and impaired memory. Explanation for Correct Answer (B): Psychological symptoms such as depression, irritability, poor concentration, and impaired memory are commonly experienced by women during the climacteric period, which includes perimenopause and menopause. These symptoms are often attributed to hormonal changes, particularly the decline in estrogen levels. Estrogen plays a role in mood regulation and cognitive function, and its reduction during menopause can lead to the onset of these psychological symptoms. Hot flushes and other physical symptoms can also exacerbate these psychological effects. Explanation for Incorrect Answers: A. They are not related to her changing levels of estrogen and progesterone: This statement is incorrect. The psychological symptoms of the climacteric, including mood swings and cognitive changes, are directly related to fluctuations and the eventual decline in estrogen and progesterone levels. Hormonal changes are a major contributing factor to these symptoms. C. They are related to a drop in gonadotropin levels: This is inaccurate. While gonadotropins (FSH and LH) are elevated during menopause due to the decline in estrogen, the psychological symptoms are primarily related to changes in estrogen levels rather than gonadotropin levels. The psychological effects are not directly caused by the drop in gonadotropins. D. They are not affected by environmental factors: This is incorrect. Environmental factors, such as stress, lifestyle, social support, and sleep quality, can significantly affect psychological symptoms during menopause. These factors may exacerbate or alleviate the symptoms, making them more complex than just being hormonally driven. E. They are primarily a reaction to the cessation of menstrual flow: While the cessation of menstrual flow is an important marker of menopause, psychological symptoms are not primarily a reaction to this. They are more related to hormonal changes, particularly the decline in estrogen, which affects mood and cognitive function.",
      "correct_choice_id": 263373,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33796421701097024/33796421701097024.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33796421701097024/33796421701097024.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88730,
      "choices": [
        {
          "id": 263377,
          "text": "Mild essential hypertension"
        },
        {
          "id": 263378,
          "text": "Chronic liver disease due to hepatitis B"
        },
        {
          "id": 263379,
          "text": "History of breast cancer"
        },
        {
          "id": 263380,
          "text": "Undiagnosed genital tract bleeding"
        }
      ],
      "text": "You are seeing four symptomatic menopausal patients in the clinic. Each patient has one of the medical conditions listed below. All of the patients wish to begin hormone replacement therapy today. The patient with which one of the following medical conditions may be started on hormone replacement therapy at the time of the visit?",
      "unique_key": "Q9504493",
      "question_audio": null,
      "question_video": null,
      "map_id": 34221944,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Mild essential hypertension. Explanation for Correct Answer (A): A patient with mild essential hypertension can be started on hormone replacement therapy (HRT) if their blood pressure is well controlled. Mild hypertension itself is not an absolute contraindication for HRT. However, it is important to monitor the patient's blood pressure regularly and ensure that it remains well-managed. Estrogen can slightly increase the risk of blood clotting and, in some cases, may contribute to higher blood pressure, so proper management of blood pressure and monitoring for any worsening is important when initiating HRT in such patients. Explanation for Incorrect Answers: B. Chronic liver disease due to hepatitis B: Chronic liver disease, particularly if it is associated with active hepatitis B, is a contraindication for HRT. The liver plays a crucial role in metabolizing hormones, and liver dysfunction can lead to impaired hormone metabolism and an increased risk of complications, such as clotting disorders. Patients with significant liver disease should not be started on HRT due to these risks. C. History of breast cancer: A history of breast cancer is a strong contraindication for HRT, especially if the cancer is estrogen receptor-positive. Estrogen can stimulate the growth of hormone-sensitive breast cancer cells, increasing the risk of recurrence. Therefore, HRT should generally be avoided in patients with a history of breast cancer. D. Undiagnosed genital tract bleeding: Undiagnosed genital tract bleeding is an absolute contraindication for initiating HRT. Any unexplained vaginal bleeding should be thoroughly investigated before starting HRT to rule out serious conditions such as endometrial cancer. Starting HRT without addressing the cause of the bleeding can mask potential issues and delay diagnosis and treatment.",
      "correct_choice_id": 263377,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72395961701097189/72395961701097189.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72395961701097189/72395961701097189.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88731,
      "choices": [
        {
          "id": 263381,
          "text": "Osteoporosis treatment"
        },
        {
          "id": 263382,
          "text": "Isolated vaginal dryness"
        },
        {
          "id": 263383,
          "text": "Treatment Hot flashes and night sweats interfering with quality of life"
        },
        {
          "id": 263384,
          "text": "Cardiovascular disease prevention"
        }
      ],
      "text": "What is an acceptable indication for Menopausal hormone therapy use?",
      "unique_key": "Q7327200",
      "question_audio": null,
      "question_video": null,
      "map_id": 34223590,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Currently, the only clinical indication for MHT is moderate to severe vasomotor symptoms (VMS), including hot flashes and night sweats. An added benefit of MHT is the prevention of osteoporosis; however, HRT should not be a first-line therapy for the treatment of osteoporosis. HRT use should be limited to the lowest dose necessary to control VMS and for the shortest period of time needed. If isolated vaginal dryness is the primary symptom, this patient would best be treated with vaginal lubricants and moisturizers first, followed by low-dose vaginal estrogen, so that there is a minimal systemic absorption. MHT should not be used to treat or prevent cardiovascular disease or dementia",
      "correct_choice_id": 263383,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50135661701097203/50135661701097203.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50135661701097203/50135661701097203.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}